Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Iovance Biotherapeutics (Silver).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

Share this video  

WCLC 2022 | Findings from the sexual health assessment in woman in lung cancer (SHAWL) study

Narjust Florez, MD, Dana Farber Cancer Institute, Boston, MA, shares findings from the sexual health assessment in woman in lung cancer (SHAWL) study. 249 woman with lung cancer were included in the study, over 60% of participants were receiving targeted therapy. Sexual health was assessed via the PROMIS questionnaire on sexual health assessment. 77% of study participants were found to have severe sexual dysfunction, with the majority of woman having little to no interest in sexual activity. The main causes of lack of interest included fatigue, shortness of breath and depression. Overall, the SHWAL study showed the prevalence of sexual dysfunction in woman with lung cancer is considerably high and needs to be addressed. This interview took place at the IASLC 2022 World Conference on Lung Cancer congress in Vienna, Austria.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.